Skip to main content

Rockefeller University

!
Phase III+: The University is open for expanded research operations; only authorized personnel will be admitted on campus. More info here.
Memory-forming neurons (green) in the brain
Science News

Why memory-forming neurons are vulnerable to Alzheimer's

Scientists have used advanced technology to “micro-dissect” the first brain cells to perish in Alzheimer’s disease. The result is a short list of genes that could represent new drug targets.
Photo of mosquito
Seek Magazine

If humans could hide 

The Aedes aegypti genome might hold clues for developing the most effective repellants yet—including ones that make the mosquito unable to smell us, or less motivated to seek us out.
Zoom screenshot of a CFC class
Campus News

How an adapting Child and Family Center supports the littlest learners in the pandemic

The CFC’s team has had to pivot quickly to create new online programming to support their young charges and provide age appropriate education and enrichment—and a measure of continuity.
Entrance to Founder's Hall
Campus News

Rockefeller statement on executive order suspending visas

The Office of the President today issued the statement below to all Rockefeller University employees. President Donald J. Trump’s ill-conceived executive order to suspend the issuing of temporary visas for foreign workers, including H1-B and J-1 visas, is detrimental to the advance of science a...
Tom Hindmarsh Sten
Campus News

David Rockefeller Fellowship awarded to graduate student Tom Hindmarsh Sten

Hindmarsh Sten receives the university’s most prestigious graduate fellowship for his work exploring the fundamental cognitive and neurological pathways underlying courtship behavior in Drosophila.
virtual convocation image
Campus News

30 young scientists receive Rockefeller Ph.D.s during virtual convocation ceremony

Since its inception, Rockefeller’s graduate program in bioscience has granted doctor of philosophy degrees to more than 1,320 students, including this year's graduates.
SARS-CoV-2 neutralizing antibodies
Science News

COVID-19 immunology study reveals universally effective antibodies

New findings characterize human antibody response to SARS-Cov-2, with implications for convalescent plasma therapy, vaccine design, and antibody-based drugs.

Hair cells in zebrafish organ
Science News

Transparent fish reveal the subtle, cellular dance in which sensory organs take shape

How do primitive cells “know” where to go during development? Scientists studying the fish equivalent of inner-ear hair cells have shown that biochemical and mechanical cues work together to orchestrate a highly complex arrangement.
Campus News

Alipasha Vaziri promoted to professor

Vaziri has created and applied new imaging techniques that capture the activity of vast numbers of neurons with record speed and spatial resolution, and at new depths.
llamas participating in research
Science News

How antibodies from llamas may lead to COVID-19 treatment

Llamas make antibodies that are much smaller than their human counterparts, yet still potent. Scientists hope that future drugs based on these molecules could provide new weapons against SARS-CoV-2.
Previous
Next
Previous
Next

Recent Awards and Honors

Junyue Cao

Junyue Cao wins Science & SciLifeLab Grand Prize For Young Scientists

November 19, 2020

Cao is recognized for his work using single-cell genomic methods to enable developmental mapping of entire organisms, described in an essay published in Science.
LLuciano Marraffini portrait

Luciano Marraffini awarded Max Planck-Humboldt Medal

October 14, 2020

Marraffini receives the award for his achievements studying CRISPR-Cas, a bacterial immune mechanism whose discovery led to modern gene-editing tools.
More awards and honors

Rockefeller in the News

Scientific American

Your Immune System Evolves to Fight Coronavirus Variants

“We have the ability to study and describe the immune system in a way we have never been able to do before. It’s an amazing window into the human immune response,” Nussenzweig says.

Knowable Magazine

Friendly Fire: How Autoantibodies Could Drive Severe Covid

Jean-Laurent Casanova's work is helping us understand how some serious cases of Covid-19 are linked with the immune system’s attack on the body it’s trying to protect.

National Geographic

How Concerned Should the U.S. Be Over Homegrown Variants?

“What this means is that good vaccines will still work. Will they work as well? That is less clear,” says Paul Bieniasz.

Seek 6 cover Fall 2020

Seek magazine

Rockefeller’s flagship publication is interested not just in scientific results, but in the people, ideas, and conversations that ignite discovery. The latest issue takes us inside the response to the pandemic, where scientists are using every tool in the 21st century playbook to transform COVID-19 into a manageable disease. Also: Mosquito menace, The brain inside your gut, and Addiction then and now.

From this issue

She’s here to make science everyone’s business

It takes a certain kind of person to make kids from all backgrounds feel at home in the world of science. And sometimes you have to dance on the internet.

Attention needs more attention

Scientists long believed they knew precisely which nooks of the brain control our ability for selective attention. Now, new findings are redrawing the maps.

 

Instagram

Subscribe to Rockefeller Science News

Did you know Rockefeller has a monthly science newsletter? Subscribe now to stay on top of the latest discoveries, news updates, and science highlights from Rockefeller’s laboratories and researchers.



Contact

Faculty at The Rockefeller University are authoritative sources on a range of topics across the biomedical sciences. For media inquiries, please contact Katherine Fenz.

Recent Scientific Publications

Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine
Application of a novel phage ZPAH7 for controlling multidrug-resistant Aeromonas hydrophila on lettuce and reducing biofilms
Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 Pneumonia